首页 | 本学科首页   官方微博 | 高级检索  
检索        


Results of a double blind study of 89-strontium therapy of skeletal metastases of prostatic carcinoma
Authors:Klaus Buchali  Hans-Jacob Correns  Michael Schuerer  Dietmar Schnorr  Hildegard Lips  Karin Sydow
Institution:(1) Klinik für Nuklearmedizin, Bereich Medizin (Charitè), Humboldt-Universität, Schuhmannstrasse 20/21, 1000 Berlin, German Democratic Republic;(2) Klinik für Urologie, Bereich Medizin (Charitè), Humboldt-Universität, Schuhmannstrasse 20/21, 1000 Berlin, German Democratic Republic
Abstract:Forty-nine patients were treated with either 3×75 MBq 89Sr or saline as placebo. Analysis of results 1 to 3 years after therapy revealed the ineffectiveness of 89Sr to relieve pain from metastases. Unexpectedly, a higher survival rate was found after Sr application (46% vs 4% after 2 years). Covariate analysis underlines the effect of 89Sr therapy on life expectation.
Keywords:Radionuclide therapy  Skeletal metastases  89-strontium
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号